Immunoinformatics and Molecular Docking Studies Predicted Potential Multiepitope-Based Peptide Vaccine and Novel Compounds against Novel SARS-CoV-2 through Virtual Screening

<div>Nonstructural protein (PDB: 6LU7) has three domains, domain I from 8-99a.a (green), domain II from 100-183a.a (cyan), and domain III from 200-306a.a (brown). A conserved binding pocket present in domain II is observed while docked with FDA ligands. Top 4 ligands from FDA library have conserved interacting residues, FDA-7 (olive green), FDA-378 (skin), FDA-592 (purple), and FDA-670 (blue).</div>

BioMed Research International

fig5

Figure 5

Figure 5: Immunoinformatics and Molecular Docking Studies Predicted Potential Multiepitope-Based Peptide Vaccine and Novel Compounds against Novel SARS-CoV-2 through Virtual Screening 

Figure 5 | Immunoinformatics and Molecular Docking Studies Predicted Potential Multiepitope-Based Peptide Vaccine and Novel Compounds against Novel SARS-CoV-2 through Virtual Screening 